Narodowy Instytut Onkologii IM. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy

The External Funds Department

UEI
RL9CDEV5ZNL1
CAGE
0969H
Primary NAICS
622310 Specialty (except Psychiatric and Substance Abuse) Hospitals
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Hospital
  • Non-Profit Organization
Entity structure
Other
SAM.gov registration date
Website
nio.gov.pl
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Grant subawards

Prime recipient Prime award Amount Awarded
University Of Pittsburgh - Of The Commonwealth System Of Higher Education Small extracellular vesicles as biomarkers of prognosis and response to therapy in head and neck cancer R01DE031299 $52,804
University Of Pittsburgh - Of The Commonwealth System Of Higher Education Small extracellular vesicles as biomarkers of prognosis and response to therapy in head and neck cancer R01DE031299 $36,226
University Of Pittsburgh - Of The Commonwealth System Of Higher Education Programmed cell death 6 interacting protein (PDCD6IP) in plasma derived exosomes: a potential prognostic biomarker of melanoma progression. W81XWH2210487 $100,000

Similar vendors

About the company

Narodowy Instytut Onkologii IM. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy operates through its External Funds Department as a sub-recipient on federal research grants focused on oncology and biomarker discovery, with no prime contract or prime grant awards in recent federal activity. This Polish non-profit research hospital participates in federally funded cancer research programs as a subordinate entity under university prime recipients, particularly the University of Pittsburgh.

The institute's federal footprint centers on National Institutes of Health grants. The top funders by award count are the National Cancer Institute (2 awards, $71 thousand combined potential value), the National Institute of Dental and Craniofacial Research (2 awards, no dollar value disclosed in the source), and the NIH Office of the Director (1 award, $7 thousand). The Defense Health Agency holds one award. These four agencies account for 86% of recent awards in the source data. The institute operates exclusively as a sub-recipient; it holds no prime contracting vehicles, IDIQs, or GSA Schedule positions. Recent sub-award work includes participation in a University of Pittsburgh-led grant on small extracellular vesicles as biomarkers of prognosis and response to therapy in head and neck cancer (sub-awards dated April 2024 and January 2024) and a December 2023 sub-award on programmed cell death 6 interacting protein in plasma-derived exosomes as a potential prognostic biomarker for melanoma progression.

Activity is sparse and episodic. The source tracks seven total awards spanning from 2005 to 2024; the frequency is irregular — one award in 2009, one in 2012, one in 2023, and two in 2024. Combined potential value across all awards is $211 thousand, though combined obligations reached $351 thousand, indicating some awards were obligated at values exceeding their potential-value ceilings. The institute holds no primary NAICS or PSC certifications or set-aside designations that drive federal competition; participation is limited to research sub-agreements under university prime recipients.

Quick answers

Is Narodowy Instytut Onkologii IM. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy registered in SAM.gov?

Narodowy Instytut Onkologii IM. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy's SAM.gov registration expired on September 24, 2024.

What is Narodowy Instytut Onkologii IM. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy's CAGE code?

Narodowy Instytut Onkologii IM. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy's CAGE code is 0969H, and its Unique Entity ID (UEI) is RL9CDEV5ZNL1.

What is Narodowy Instytut Onkologii IM. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy's most recent federal award?

Narodowy Instytut Onkologii IM. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy's most recent federal contract award is (other functions) collect follow up information from breast and ovarian cancer case-control study (HHSN261201200421P), from National Cancer Institute (NIH), on September 24, 2012.

On GovTribe

See Narodowy Instytut Onkologii IM. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe